Open AccessBrief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV
Author(s) -
Elisabeth McClymont,
François Coutlée,
Marette Lee,
Arianne Albert,
Janet Raboud,
Sharon Walmsley,
Nancy Lipsky,
Mona Loutfy,
Sylvie Trottier,
Fiona Smaill,
Marina B. Klein,
Mark H. Yudin,
Marianne Harris,
Wendy Wobeser,
Ari Bitnun,
Lindy Samson,
Deborah Money,
Ctn Hpv in Hiv Study Team
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002258
Subject(s) - medicine , incidence (geometry) , vaccination , immunogenicity , cohort , hpv infection , hpv vaccines , young adult , cohort study , immunology , virology , cancer , cervical cancer , antibody , physics , optics
Human papillomavirus (HPV) vaccines have promising safety and immunogenicity data in women living with HIV (WLWH). However, it is critical to understand the residual burden of oncogenic HPV within WLWH to inform postvaccination cervical screening needs. We assessed rates of persistent infection with nonquadrivalent HPV (qHPV) oncogenic types in a cohort of qHPV-vaccinated WLWH.